Bayer Aleve
NDC 0924-6000, Naproxen Sodium, tablet, from Acme United Corporation.
- Product NDC
- 0924-6000
- Status
- Listed
- Labeler
- Acme United Corporation
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- NDA
- Application
- NDA020204
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0924-6000 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPROXEN SODIUM220 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0924-6000-00 | 00924600000 | 1 TABLET in 1 POUCH (0924-6000-00) |
| 0924-6000-01 | 00924600001 | 50 POUCH in 1 BOX (0924-6000-01) / 1 TABLET in 1 POUCH |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0924-6000 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0924-6000 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0924-6000. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.